Colorectal cancer (CRC) remains a major global health burden, ranking as the third most commonly diagnosed malignancy in men and the second in women. Despite improvements in screening and treatment, CRC continues to cause substantial morbidity and mortality, especially in developing nations. This article discusses the worldwide and Indian scenario, epidemiological trends, survival challenges, and the need for better clinicopathological profiling to enhance outcomes.
Colorectal cancer (CRC) is a malignancy of the gastrointestinal tract with high worldwide prevalence, responsible for significant patient suffering, treatment costs, and burden on healthcare systems. It is the third most common cancer in men and the second most common in women globally [1]. Almost 60% of CRC cases occur in developed regions, with incidence rates varying almost tenfold worldwide. Australia, New Zealand, and Western Europe report the highest rates, while Africa and South-Central Asia observe the lowest [1].
Global and Regional Distribution
The global burden of CRC highlights significant geographical disparities. In developed countries, higher incidence rates are attributed to dietary patterns, obesity, and sedentary lifestyles. In high-incidence regions, approximately 25% of CRCs involve the rectum, with rectal cancers more common in men (30%) compared to women (21%) [2]. Lifetime risk of CRC is approximately 5-6% in the Western world, with more than 50% of individuals affected by the age of 70, reflecting its public health significance [3].
Notably, racial and ethnic variations have been observed. African Americans in the United States exhibit higher incidence rates compared to Caucasians, while Asian Americans, Native Americans, and Hispanic populations demonstrate comparatively lower rates (4). Ashkenazi Jews are known to have a slightly increased genetic predisposition to CRC [4].
Colorectal Cancer in India
India’s age-standardized rate (ASR) for CRC is relatively low, at 7.2 per 100,000 males and 5.1 per 100,000 females [5]. However, given India’s massive population, the absolute number of CRC cases remains significant. CRC accounts for the seventh most common cancer in India, with 65,358 new cases reported in 2021 (18). Unlike Western countries, where CRC primarily affects the
elderly, India reports a higher proportion of younger patients, especially those under 50 years.
A major concern is the dismal five-year survival rate, which remains below 40% (6). Data from the CONCORDE-2 study revealed that survival rates are stagnant or even worsening in certain Indian registries, indicating serious gaps in timely diagnosis and access to effective treatments [6].
Shifts in Epidemiology
Globally, while CRC incidence is stabilizing or declining in some developed countries due to effective screening programs, it is rising rapidly in developing economies, including parts of Asia. Japan, South Korea, and Singapore have witnessed steep increases, correlating with urbanization and Westernized lifestyles [13]. Within India, while urban areas show a modest increase in colon cancer cases, rural populations demonstrate disproportionately higher rates of rectal cancers [18].
This variation may be attributed to different dietary patterns, physical inactivity, and healthcare access. Alarmingly, age-sex adjusted rates of CRC in India increased by 20.6% between 2004 and 2014, with a steeper rise among younger adults under 50 years [18].
Challenges in the Indian Context
Several challenges impede CRC management in India. Limited awareness, delayed presentation, inadequate screening infrastructure, and high treatment costs contribute to poor outcomes. Late-stage presentation remains common, with over 50% of patients diagnosed at Stage III or IV [3, 18].
Compounding these issues is the limited availability of advanced diagnostic imaging, genetic testing, and personalized therapies. Rural populations, in particular, suffer from significant disparities in healthcare access, exacerbating the burden.
Colorectal cancer is a rising concern globally and in India. Differences in demographic profiles, tumor locations, and survival outcomes highlight the urgent need for comprehensive clinicopathological profiling. Systematic national screening programs, public education campaigns, better access to healthcare services, and more robust cancer registries are crucial for improving survival rates in India.
Bray, F., et al. "Global Cancer Statistics 2018: GLOBOCAN Estimates." CA: A Cancer Journal for Clinicians, vol. 68, no. 6, 2018, pp. 394–424.
Arnold, M., et al. "Global Patterns and Trends in Colorectal Cancer Incidence and Mortality." Gut, vol. 66, no. 4, 2017, pp. 683–691.
Siegel, R.L., et al. "Colorectal Cancer Statistics, 2020." CA: A Cancer Journal for Clinicians, vol. 70, no. 3, 2020, pp. 145–164.
Murphy, C.C., et al. "Racial Disparities in Incidence of Young-Onset Colorectal Cancer." JAMA Surgery, vol. 155, no. 6, 2020, pp. 524–527.
Global Burden of Disease Cancer Collaboration. "Global Burden of Colorectal Cancer." The Lancet Oncology, vol. 20, no. 7, 2019, pp. 913–933.
Allemani, C., et al. "CONCORD-2: Worldwide Comparison of Cancer Survival." The Lancet, vol. 385, no. 9972, 2015, pp. 977–1010.
Center, M.M., et al. "International Trends in Colorectal Cancer Incidence Rates." Cancer Epidemiology Biomarkers & Prevention, vol. 18, no. 6, 2009, pp. 1688–1694
Ferlay, J., et al. "GLOBOCAN 2018: Cancer Incidence and Mortality Worldwide." International Journal of Cancer, vol. 144, no. 8, 2019, pp. 1941–1953.
Sung, H., et al. "Global Cancer Statistics 2020: GLOBOCAN Estimates." CA: A Cancer Journal for Clinicians, vol. 71, no. 3, 2021, pp. 209–249.
Douaiher, J., et al. "Colorectal Cancer: A Multidisciplinary Overview." Surgical Clinics of North America, vol. 97, no. 3, 2017, pp. 631–646.